Anti-Diabetic Medications: A promising therapeutic approaches for the Management of NAFLD

Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy

Sodium Glucose Transporter 2 Inhibitor as a Novel Therapy for Patients with Chronic Hyponatremia

RESVERATROL LIPID BASED NANOPARTICLES SHOW A PROMISING OUTCOME ON INDUCED NON ALCOHOLIC FATTY LIVER DISEASE

Protective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation

Non-Alcoholic Fatty Liver Disease

Insulin Resistance and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease

The Beneficial Effects of Sitagliptin, a Dipeptedyl Peptidase-4 (DPP-4) Inhibitor on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

Non alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment

Nonalcoholic Fatty Liver Disease (NAFLD)